Literature DB >> 27706476

Successful Treatment of Refractory Pityriasis Rubra Pilaris With Secukinumab.

Daniel Schuster1, Andrea Pfister-Wartha1, Leena Bruckner-Tuderman1, Christoph M Schempp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27706476     DOI： 10.1001/jamadermatol.2016.3885

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  7 in total

1.  Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Authors:  Dylan Haynes; Jennifer L Strunck; Christina A Topham; Alex G Ortega-Loayza; Gail Kent; Pamela B Cassidy; Ronghua Hu; Keith Choate; Zhiping Wang; Yuangang Liu; Teri M Greiling
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

Review 2.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09

3.  Secukinumab in pityriasis rubra pilaris: A case series demonstrating variable response and the need for minimal clinical datasets.

Authors:  Tevi Wain; Bonita Choy; Andrew C Satchell; Jane A Woods; John W Frew
Journal:  JAAD Case Rep       Date:  2018-05-07

Review 4.  The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Authors:  Taoming Liu; Sheng Li; Shuni Ying; Shunli Tang; Yuwei Ding; Yali Li; Jianjun Qiao; Hong Fang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

5.  Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.

Authors:  Kathrin Hanfstingl; Agnes Pekar-Lukacs; Reinhard Motz; Emmanuella Guenova; Wolfram Hoetzenecker
Journal:  Case Rep Dermatol       Date:  2018-05-02

6.  Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl.

Authors:  Lauren Bonomo; Aishwarya Raja; Kathryn Tan; Emma Guttman-Yassky
Journal:  JAAD Case Rep       Date:  2018-02-09

7.  Successful treatment of type I pityriasis rubra pilaris with ixekizumab.

Authors:  Mark D Heibel; Haley D Heibel
Journal:  JAAD Case Rep       Date:  2018-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.